3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
5
Colorectal Neoplasms
4
Colonic Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Klatskin Tumor
2
Gallbladder Neoplasms
2
Cholangiocarcinoma
2
Tongue Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Pancreatic Intraductal Neoplasms
1
PRETEXT I Hepatoblastoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Lymphoid Interstitial Pneumonia
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Clinical Stage I Gastric Cancer AJCC v8
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Bile Duct Neoplasms
1
Interventions
Oxaliplatin
5
Leucovorin
5
Capecitabine
5
Fluorouracil
4
Erlotinib Hydrochloride
4
Trastuzumab
3
trametinib
2
pembrolizumab
2
Sorafenib
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Lapatinib
2
Interleukin-12 Subunit p35
2
Gemcitabine
2
Floxuridine
2
Chemotherapy, Adjuvant
2
AZD 6244
2
tremelimumab
1
tivozanib
1
tipifarnib
1
motexafin lutetium
1
ixabepilone
1
entinostat
1
durvalumab
1
dehydroftorafur
1
cediranib
1
Watchful Waiting
1
Specimen Handling
1
Radiotherapy
1
Radiofrequency Ablation
1
Phototherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Bile Duct Neoplasms
×
dehydroftorafur
×
Clear all
NCT02042443
2017-09-12
S1310
National Cancer Institute (NCI)
Phase 2
Completed
53 enrolled
13 charts